Multiple Sites of Inhibition of Mitochondrial Electron Transport by Local Anesthetics
Overview
Biophysics
Authors
Affiliations
Local anesthetics and alcohols were found to inhibit mitochondrial electron transport at several points along the chain. THe anesthetics employed were the tertiary amines procaine, tetracaine, dibucaine, and chlorpromazine, and the alcohols were n-butamol, n-pentanol, n-hexanol, and benzyl alcohol. Uncoupled sonic submitochondrial particles from beef heart and rat liver were studied. We report the following: (1) All of the anesthetics were found to inhibit each of the segments of the electron transport chain assayed; these included cytochrome c oxidase, durohydroquinone oxidase, succinate oxidase, NADH oxidase, succinate dehydrogenase, succinate-cytochrome c oxidoreductase, and NADH-cytochrome c oxidoreductase. (2) NADH oxidase and NADH-cytochrome c oxidoreductase required the lowest concentration of anesthetic for inhibition, and cytochrome c oxidase required the highest concentrations. (3) We conclude that there are several points along the chain at which inhibition occurs, the most sensitive being in the region of Complex I (NADH dehydrogenase). (4) Beef heart submitochondrial particles are less sensitive to inhibition than are rat liver particles. (5) Low concentrations of several of the anesthetics gave enhancement of electron transport activity, whereas higher concentrations of the same agents caused inhibition. (6) The concentrations of anesthetics (alcohol and tertiary amine) which gave 50% inhibition of NADH oxidase were lower than the reported concentrations required for blockage of frog sciatic nerve.
Shalaby M, Sahni R, Hamilton R Clin Exp Emerg Med. 2024; 11(2):121-126.
PMID: 38778495 PMC: 11237253. DOI: 10.15441/ceem.24.231.
Tiszlavicz A, Gombos I, Peter M, Hegedus Z, Hunya A, Dukic B Biomedicines. 2022; 10(5).
PMID: 35625909 PMC: 9138356. DOI: 10.3390/biomedicines10051172.
[Imaging of oligometastatic disease in selected urologic cancers].
Koerber S, Fink C, Dendl K, Schmitt D, Niegisch G, Mamlins E Urologe A. 2021; 60(12):1561-1569.
PMID: 34850260 DOI: 10.1007/s00120-021-01708-0.
[Treatment of primary oligometastatic prostate cancer].
Scharl S, Hadaschik B, Wiegel T, Thomas C Urologe A. 2021; 60(12):1527-1533.
PMID: 34825936 DOI: 10.1007/s00120-021-01643-0.
Du K, McGill M, Xie Y, Jaeschke H Food Chem Toxicol. 2015; 86:253-61.
PMID: 26522885 PMC: 4691387. DOI: 10.1016/j.fct.2015.10.016.